240 related articles for article (PubMed ID: 26151555)
21. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
Soeters HM; Sawry S; Moultrie H; Rie AV
J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
[TBL] [Abstract][Full Text] [Related]
22. Impact of antiretroviral treatment on height evolution of HIV infected children.
Traisathit P; Urien S; Le Coeur S; Srirojana S; Akarathum N; Kanjanavanit S; Ngampiyaskul C; Krikajornkitti S; Ngo-Giang-Huong N; Lallemant M; Jourdain G
BMC Pediatr; 2019 Aug; 19(1):287. PubMed ID: 31421667
[TBL] [Abstract][Full Text] [Related]
23. CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence.
Simms V; Rylance S; Bandason T; Dauya E; McHugh G; Munyati S; Mujuru H; Rowland-Jones SL; Weiss HA; Ferrand RA
AIDS; 2018 Sep; 32(14):1977-1982. PubMed ID: 29927784
[TBL] [Abstract][Full Text] [Related]
24. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O;
Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345
[TBL] [Abstract][Full Text] [Related]
25. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
[TBL] [Abstract][Full Text] [Related]
26. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.
Nash D; Wu Y; Elul B; Hoos D; El Sadr W;
AIDS; 2011 Jul; 25(12):1523-33. PubMed ID: 21750418
[TBL] [Abstract][Full Text] [Related]
27. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
[TBL] [Abstract][Full Text] [Related]
28. Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
Prendergast AJ; Szubert AJ; Berejena C; Pimundu G; Pala P; Shonhai A; Musiime V; Bwakura-Dangarembizi M; Poulsom H; Hunter P; Musoke P; Kihembo M; Munderi P; Gibb DM; Spyer M; Walker AS; Klein N;
J Infect Dis; 2016 Jul; 214(2):226-36. PubMed ID: 27190179
[TBL] [Abstract][Full Text] [Related]
29. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa.
Bärnighausen T; Tanser F; Malaza A; Herbst K; Newell ML
Trop Med Int Health; 2012 Aug; 17(8):e103-10. PubMed ID: 22943374
[TBL] [Abstract][Full Text] [Related]
30. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
31. Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children.
Yotebieng M; Van Rie A; Moultrie H; Meyers T
AIDS; 2010 Jan; 24(1):139-46. PubMed ID: 19940744
[TBL] [Abstract][Full Text] [Related]
32. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
33. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART.
Ujeneza EL; Ndifon W; Sawry S; Fatti G; Riou J; Davies MA; Nieuwoudt M;
Elife; 2021 Jan; 10():. PubMed ID: 33443013
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
Leroy V; Malateste K; Rabie H; Lumbiganon P; Ayaya S; Dicko F; Davies MA; Kariminia A; Wools-Kaloustian K; Aka E; Phiri S; Aurpibul L; Yiannoutsos C; Signaté-Sy H; Mofenson L; Dabis F;
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):208-19. PubMed ID: 23187940
[TBL] [Abstract][Full Text] [Related]
35. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
[TBL] [Abstract][Full Text] [Related]
36. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
[TBL] [Abstract][Full Text] [Related]
37. Composition of Gut Microbiota of Children and Adolescents With Perinatal Human Immunodeficiency Virus Infection Taking Antiretroviral Therapy in Zimbabwe.
Flygel TT; Sovershaeva E; Claassen-Weitz S; Hjerde E; Mwaikono KS; Odland JØ; Ferrand RA; Mchugh G; Gutteberg TJ; Nicol MP; Cavanagh JP; Flægstad T;
J Infect Dis; 2020 Jan; 221(3):483-492. PubMed ID: 31549151
[TBL] [Abstract][Full Text] [Related]
38. Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa.
Zanoni BC; Phungula T; Zanoni HM; France H; Cook EF; Feeney ME
PLoS One; 2012; 7(3):e33611. PubMed ID: 22438965
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
Trials; 2013 Jul; 14():230. PubMed ID: 23880306
[TBL] [Abstract][Full Text] [Related]
40. Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Penazzato M; Prendergast AJ; Muhe LM; Tindyebwa D; Abrams E
Cochrane Database Syst Rev; 2014 May; 2014(5):CD004772. PubMed ID: 24852077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
